Merger-killing ego: does it strangle Indian pharma superpower ambitions before birth?
This article was originally published in Scrip
Executive Summary
"Despite all the seeming cultural and other issues, if Dr Anji Reddy [the founder of Dr Reddy's Laboratories] and Dr Yusuf Hamied [Cipla's chairman and managing director] can come together and merge their businesses, it will be a great day not only for Indian pharma but for the country." So says Dr Brian Tempest, an ex-CEO of Ranbaxy Laboratories and currently an advisor to MAPE, a mid-market investment bank, and the United Nations Conference on Trade and Development, among other positions.
You may also be interested in...
India M&A Uptick: Have The Planets Aligned?
The recent uptick in M&A on the Indian pharmaceutical market points to tempered valuations and the potential for further consolidation. Scrip spoke to a cross-section of experts including investment bankers on deal street expectations, foreign interest in M&A and whether family-led Indian firms may now be more open to sell-offs.
India IPR Realities: Pharma, Legal Heads Discuss Winds Of Change, ‘Damocles Sword’
Leaders from Novartis, Bayer, Sun Pharma, the Indian Pharmaceutical Alliance, Médecins Sans Frontières and Anand and Anand discuss India’s evolving intellectual property rights landscape, including pre-grant oppositions, enforcement action and other realities. Concerns around evergreening, restrictions on patent-eligible subject matter and compulsory licensing were also key talking points at a recent conference in Hyderabad.
India IPR Wheels Are Turning: Novartis, Bayer, Sun, Legal Heads Discuss Realities
Leaders from Novartis, Bayer, Sun Pharma, the Indian Pharmaceutical Alliance, Médecins Sans Frontières and Anand and Anand discuss India’s evolving intellectual property rights landscape, including pre-grant oppositions, enforcement action and other realities. Concerns around evergreening, restrictions on patent-eligible subject matter and compulsory licensing were also key talking points at a recent conference in Hyderabad.